| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 815-819, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
R Anbazhagan, H Fujii and E Gabrielson
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Loss of heterozygosity (LOH) of chromosomal arm 8p has been reported to occur at high frequency for a number of common forms of human cancer, including breast cancer. The objectives of this study were to define the regions on this chromosomal arm that are likely to contain breast cancer tumor suppressor genes and to determine when loss of chromosomal arm 8p occurs during breast cancer progression. For mapping the tumor suppressor gene loci, we evaluated 60 cases of infiltrating ductal cancer for allelic loss using 14 microsatellite markers mapped to this chromosomal arm and found LOH of 8p in 36 (60%) of the tumors. Whereas most of these tumors had allelic loss at all informative markers, five tumors had partial loss of 8p affecting two nonoverlapping regions. LOH for all but one of the tumors with 8p loss involved the region between markers D8S560 and D8S518 at 8p21.3-p23.3, suggesting that this is the locus of a breast cancer tumor suppressor gene. We then studied LOH of 8p in 38 cases of ductal carcinoma in situ (DCIS) with multiple individually microdissected tumor foci evaluated for each case. LOH of 8p was found in 14 of the DCIS cases (36%), including 6 of 16 cases of low histological grade and 8 of 22 cases of intermediate or high histological grade. In four of these DCIS cases, 8p LOH was seen in some but not all of the multiple tumor foci examined. These data suggest that during the evolution of these tumors, LOH of 8p occurred after loss of other chromosomal arms that were lost in all tumor foci. Thus, LOH of 8p, particularly 8p21.3-p23, is a common genetic alteration in infiltrating and in situ breast cancer. Although 8p LOH is common even in low histological grade DCIS, this allelic loss often appears to be preceded by loss of other alleles in the evolution of breast cancer.
This article has been cited by other articles:
 |
|
 |
|
  J. Zhang, S. L. Planey, C. Ceballos, S. M. Stevens Jr., S. K. Keay, and D. A. Zacharias Identification of CKAP4/p63 as a Major Substrate of the Palmitoyl Acyltransferase DHHC2, a Putative Tumor Suppressor, Using a Novel Proteomics Method Mol. Cell. Proteomics, July 1, 2008; 7(7): 1378 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Nonaka, A. Fabbri, L. Roz, L. Mariani, A. Vecchione, G. W. Moore, L. Tavecchio, C. M. Croce, and G. Sozzi Reduced FEZ1/LZTS1 Expression and Outcome Prediction in Lung Cancer Cancer Res., February 15, 2005; 65(4): 1207 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Ellsworth, R. E. Ellsworth, B. Love, B. Deyarmin, S. M. Lubert, V. Mittal, J. A. Hooke, and C. D. Shriver Outer Breast Quadrants Demonstrate Increased Levels of Genomic Instability Ann. Surg. Oncol., September 1, 2004; 11(9): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Ray, Z. Q. Yang, D. Albertson, C. G. Kleer, J. G. Washburn, J. A. Macoska, and S. P. Ethier Genomic and Expression Analysis of the 8p11-12 Amplicon in Human Breast Cancer Cell Lines Cancer Res., January 1, 2004; 64(1): 40 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Wascher, K. T. Huynh, A. E. Giuliano, N. M. Hansen, F. R. Singer, D. Elashoff, and D. S. B. Hoon Stanniocalcin-1: A Novel Molecular Blood and Bone Marrow Marker for Human Breast Cancer Clin. Cancer Res., April 1, 2003; 9(4): 1427 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ishii, A. Vecchione, Y. Murakumo, G. Baldassarre, S. Numata, F. Trapasso, H. Alder, R. Baffa, and C. M. Croce FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis PNAS, August 10, 2001; (2001) 181222898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Shin, H. S. Kim, S. H. Lee, W. S. Park, S. Y. Kim, J. Y. Park, J. H. Lee, S. K. Lee, S. N. Lee, S. S. Jung, et al. Mutations of Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor 1 (TRAIL-R1) and Receptor 2 (TRAIL-R2) Genes in Metastatic Breast Cancers Cancer Res., July 1, 2001; 61(13): 4942 - 4946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. I. Sigbjörnsdottir, G. Ragnarsson, B. A. Agnarsson, C. Huiping, R. B. Barkardottir, V. Egilsson, and S. Ingvarsson Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer J. Med. Genet., May 1, 2000; 37(5): 342 - 347. [Abstract] [Full Text]
|
|
|
|
|
|
R. Baffa, R. Santoro, F. Bullrich, B. Mandes, H. Ishii, and C. M. Croce Definition and Refinement of Chromosome 8p Regions of Loss of Heterozygosity in Gastric Cancer Clin. Cancer Res., April 1, 2000; 6(4): 1372 - 1377. [Abstract] [Full Text]
|
|
|
|
|
|
N. Shivapurkar, S. Sood, I. I. Wistuba, A. K. Virmani, A. Maitra, S. Milchgrub, J. D. Minna, and A. F. Gazdar Multiple Regions of Chromosome 4 Demonstrating Allelic Losses in Breast Carcinomas Cancer Res., August 1, 1999; 59(15): 3576 - 3580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishii, R. Baffa, S.-I. Numata, Y. Murakumo, S. Rattan, H. Inoue, M. Mori, V. Fidanza, H. Alder, and C. M. Croce The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors PNAS, March 30, 1999; 96(7): 3928 - 3933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishii, A. Vecchione, Y. Murakumo, G. Baldassarre, S. Numata, F. Trapasso, H. Alder, R. Baffa, and C. M. Croce FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis PNAS, August 28, 2001; 98(18): 10374 - 10379. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
